Marla S. Persky's Insider Trades & SAST Disclosures

Marla S. Persky's most recent trade in Xeris Biopharma Holdings Inc was a trade of 50,000 Common Stock done . Disclosure was reported to the exchange on June 4, 2025.

Share

Note

This is a custom search result for pattern Marla S. Persky.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Xeris Biopharma Holdings Inc High Gain High Volume	Marla S. Persky	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jun 2025	50,000	157,500 (0%)	0%		0	Common Stock
Xeris Biopharma Holdings Inc High Gain High Volume	Marla S. Persky	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	50,000	107,500 (0%)	0%		0	Common Stock
Xeris Biopharma Holdings Inc High Gain High Volume	Marla S. Persky	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Jun 2023	42,500	57,500 (0%)	0%		0	Common Stock
Xeris Biopharma Holdings Inc High Gain High Volume	Marla S. Persky	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jun 2022	25,000	25,000	-		-	Stock Option (Right to Buy)
Xeris Biopharma Holdings Inc High Gain High Volume	Marla S. Persky	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jun 2022	15,000	15,000 (0%)	0%		0	Common Stock
Xeris Biopharma Holdings Inc High Gain High Volume	Marla S. Persky	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	05 Oct 2021	20,000	0	-		-	Stock Option (Right to Buy)
Xeris Biopharma Holdings Inc High Gain High Volume	Marla S. Persky	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Oct 2021	20,000	20,000	-		-	Stock Option (Right to Buy)
Xeris Biopharma Holdings Inc High Gain High Volume	Marla S. Persky	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	05 Oct 2021	19,650	0	-		-	Stock Option (Right to Buy)
Xeris Biopharma Holdings Inc High Gain High Volume	Marla S. Persky	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Oct 2021	19,650	19,650	-		-	Stock Option (Right to Buy)
Xeris Biopharma Holdings Inc High Gain High Volume	Marla S. Persky	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	05 Oct 2021	11,228	0	-		-	Stock Option (Right to Buy)
Xeris Biopharma Holdings Inc High Gain High Volume	Marla S. Persky	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Oct 2021	11,228	11,228	-		-	Stock Option (Right to Buy)
Xeris Biopharma Holdings Inc High Gain High Volume	Marla S. Persky	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Oct 2021	11,228	11,228	-		-	Stock Option (Right to Buy)
Xeris Biopharma Holdings Inc High Gain High Volume	Marla S. Persky	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	05 Oct 2021	11,228	0	-		-	Stock Option (Right to Buy)
Xeris Biopharma Holdings Inc High Gain High Volume	Marla S. Persky	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jun 2021	11,228	11,228	-		-	Stock Option (Right to Buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades